3S Corporation is one of India’s leading stockist, exporter & wholesaler for Anti-cancer drug & Oncology medicines. We even supply & export Sex Enhancement Drugs, Cardiac & Anti Diabetic Medicines. We are a registered wholesaler & exporter for pharmaceutical products licensed by our FDA and Drug Controller in India. Our license number are 20-B/MZ6-23015 & 21-B/ MZ6-23016.
Andheri East, Mumbai - 400099,
All the pharmaceutical products we offer are prescription drugs and should be used/taken under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug. We are not an online pharmacy . We do not recommend any drug or give medical advice. We only express opinions and provide information. Whether a medication is right for you is a decision between you and the prescribing doctor. Kindly seek medical advice from a registered doctor 0r hospital/Institution before taking any of these medicines.
Estramustine Phosphate Capsules BP 140 mg is used in palliative therapy of metastatic or progressive prostate cancer. Estramustine appears to act as a relatively weak alkylating agent and imparts a weak estrogenic activity. The estrogenic portion of the molecule acts as a carrier to facilitate selective uptake of the drug into estrogen receptor-positive cells. Because of the selective steroidal uptake, the alkylating effect of the nitrogen mustard is enhanced in these cells. Estramustine phosphate is readily dephosphorylated during absorption, and the major metabolites in plasma are estramustine, the estrone analog, estradiol, and estrone.
India has many manufacturers who manufacture Estramustine Phosphate Capsules BP 140 mg .To know more contact us.
3s corporation is Supplier,Exporter ,Wholesaler for Estramustine Phosphate Capsules BP 140 mg in India.
Dose in Prostate Cancer Adults
14 mg/kg/day (range, 10 to 16 mg/kg/day) in 3 to 4 divided doses for 30 to 90 days before assessing for continuation of therapy. Continue therapy as long as response is favorable.
Administer with water 1 h or more before or 2 h after meals.
Hypertension; CHF; edema; increased risk of cerebrovascular accident; MI, thrombosis.
Lethargy; emotional lability; insomnia.
Rash; pruritus; dry skin; easy bruising.
Decreased glucose tolerance; breast tenderness or enlargement.